Cipla Gets U.S. FDA Warning Letter For Goa Unit

Cipla Ltd. said it has received a “warning letter” from the U.S. drug regulator for its formulations plant in Goa.That comes after the U.S. Food and Drug Administration classified the plant as Offi...